News
11h
Zacks Investment Research on MSNWall Street Analysts Think Arcturus Therapeutics (ARCT) Could Surge 371.35%: Read This Before Placing a BetShares of Arcturus Therapeutics (ARCT) have gained 7.5% over the past four weeks to close the last trading session at $12.81, ...
6d
Fintel on MSNScotiabank Initiates Coverage of Arcturus Therapeutics Holdings (ARCT) with Sector Outperform RecommendationFintel reports that on May 28, 2025, Scotiabank initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a ...
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicine company focused on the development of infectious disease vaccines and ...
Now three months past its conjunction with the sun in March, Saturn is currently well separated from the dawn glow. On June 1 ...
1dOpinion
Ottawa Citizen on MSNDeonandan: Cancelling funding for mRNA vaccine is both risky and foolishThe withdrawal of the U.S. from efforts to produce an mRNA vaccine against H5N1 is indeed troubling. When it infects humans, ...
If you’re a night owl, this is the perfect time of year for you, as stargazing has now become a late-night delight! Catch an ...
On Wednesday, Scotiabank (TSX: BNS) began coverage on Arcturus Therapeutics (NASDAQ: ARCT), assigning a Sector Outperform rating and setting a price target of $32.00.Currently trading at $11.77 ...
Venus continues to be the brilliant “Morning Star” in the East before dawn, albeit dimming just a bit as it moves away from ...
June’s night skies provide excellent opportunities to discover a slice of the evening sky that is largely unsung, unheralded ...
If you’re a night owl, this is the perfect time of year for you, as stargazing has now become a late-night delight! Catch an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results